Scientists reprogram Patient's own cells to hunt deadly sarcoma
NCT ID NCT00902044
Summary
This study is testing a new treatment for advanced sarcoma, a type of cancer. Doctors take a patient's own immune cells (T-cells), genetically modify them in a lab to recognize and attack cancer cells, and then infuse them back into the patient. The main goals are to find the safest dose of these modified cells and to see if this approach can help control the cancer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SARCOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Houston Methodist Hospital
Houston, Texas, 77030, United States
-
Texas Children's Hospital
Houston, Texas, 77030, United States
Conditions
Explore the condition pages connected to this study.